副所院长王建祥带领的研讨团队在《Blood》宣布新效果

  副所院长王建祥带领的研讨团队在世界血液学范畴的中心期刊《Blood》宣布题为"TBLR1 fuses to retinoid acid receptor alpha in a variant t(3;17)(q26;q21) translocation of acute promyelocytic leukemia”的研讨论文。

   英文摘要

   The majority of acute promyelocytic leukemia (APL) cases are characterized by PML-RARα fusion gene. Although PML-RARα fusion gene can be detected in more than 98% of APL cases, RARα is also found to be fused with other partner genes, which are also related to all-trans retinoic acid (ATRA) dependent transcriptional activity and cell differentiation. In this study, we identified a novel RARα fusion gene, TBLR1-RARα (GenBank KF589333), in a rare case of APL with a t(3;17)(q26;q21), t(7;17)(q11.2;q21) complex chromosomal rearrangement. To our knowledge, TBLR1-RARα is the tenth RARα chimeric gene which has been reported up to now. TBLR1-RARα contained the B-F domains of RARα, exhibited a distinct subcellular localization. It could form homodimers and also heterodimers with RXRα. As a result, TBLR1-RARα exhibited diminished transcriptional activity by recruitment of more transcriptional corepressors compared with RARα. In the presence of pharmacological doses of ATRA, TBLR1-RARα could be degraded and its homodimerization was abrogated. Moreover, when treated with ATRA, TBLR1-RARα could mediate the dissociation and degradation of transcriptional corepressors, consequent transactivation of RARα target genes and cell differentiation induction in a dose- and time-dependent manner.

  点击(速度有点慢,请耐性等候)

  手机阅览

   
网站导航 | 联络咱们 | 运用协助 | 网站声明


主办:fun88血液学研讨所血液病医院  技术支持:北方网
  存案序号:
主张运用IE6.0以上浏览器,分辨率1024*768